The House Dec. 11 voted 320-71 to pass legislation (H.R. 5378) that would delay a Jan. 19 payment reduction to Medicaid disproportionate share hospitals for two years, but permanently reduce Medicare payments for drug administration services in off-campus hospital outpatient departments. Among other provisions, the bill codifies the Hospital Price Transparency Rule but makes key changes, including no longer allowing the use of price estimator tools to meet the shoppable services requirement and increasing civil monetary penalties for noncompliance.

“While the AHA appreciates inclusion of a two-year delay on DSH cuts, we have been very clear regarding the harm that would be done to our nation’s hospitals if so-called site-neutral cuts to Medicare were adopted,” AHA President and CEO Rick Pollack said in a statement shared yesterday with reporters and House members. 

Headline
The Centers for Medicare & Medicaid Services March 6 issued guidance to states on transitioning to six-month Medicaid redeterminations in 2027, a change…
Headline
Republican leaders on the House Committee on Energy and Commerce March 5 announced they were expanding their ongoing investigation into waste, fraud and abuse…
Headline
The Centers for Medicare & Medicaid Services has released a toolkit that outlines strategies for states to strengthen access to behavioral health services…
Headline
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
The AHA provided a statement Feb. 24 for a House Ways and Means Health Subcommittee hearing titled “Advancing the Next Generation of America’s Health Care…
Headline
The AHA Feb. 17 submitted a comment letter responding to the Centers for Medicare & Medicaid Services’ proposed rule that would prohibit hospitals…